Document is current
Any future updates will be listed below
-
Authors
Pizzino, Amy
Arnold, Kaley
Wiener, Emma
Muirhead, Kayla
Schmidt, Johanna
Dominguez-Gonzalez, Carlos A.
Banglorewala, Pooja
Fraser, Jamie L.
Ruzhnikov, Maura
Cohen, Julie S.
Sherbini, Omar
Logan, Rachel
Gavazzi, Francesco
Sevagamoorthy, Anjana
Vincent, Ariel
D’Aiello, Russell
Vanderver, Adeline
-
Funding
Funding for this research was provided by:
National Institutes of Health (U54NS115052)
- License Information
-
More Information
Article History
Received: 4 November 2025
Accepted: 9 March 2026
First Online: 28 April 2026
Declarations
:
: The Myelin Disorders Biorepository Project (MDBP) is reviewed and approved by the Children’s Hospital of Philadelphia (CHOP IRB #14-011236). All research was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: AP, KA, EW, KM, JS, CD, PB, JLF, MR, JC, OS, RL, FG, AS, AVi, and RDA have no disclosures. AVa receives research support from Eli Lilly, Boehringer Ingelheim, Biogen, Immunesensor, Synaptixbio, Sanofi, Affinia, Orchard, Homology, Myrtelle, Bluebirdbio, Ionis, Illumina.
